Partnership15 May 2026, 05:21 pm
Godfrey Phillips Inks Distribution Deal with Aspeya India
AI Summary
Godfrey Phillips India Ltd has approved a Distribution Agreement with Aspeya India Private Limited for the distribution/re-sale of Nicotine Replacement Therapy Products. The agreement, with an initial term of 3 years, will enable Godfrey Phillips to leverage its distribution network to distribute Aspeya's products, potentially boosting its revenue and profit. Aspeya, a member entity of the Group to which Philip Morris Global Brands Inc belongs, reported revenue from operations of ₹795.06 lakhs and a profit after tax of ₹19.32 lakhs for the year ended March 31, 2025.
Key Highlights
- Godfrey Phillips to distribute Aspeya India's Nicotine Replacement Therapy Products.
- The distribution agreement has an initial term of 3 years.
- Aspeya's revenue from operations stood at ₹795.06 lakhs in FY25.
- The deal is expected to improve Godfrey Phillips' top-line and bottom-line.
- Transactions will be at arm's length as Aspeya is part of Philip Morris group.
Price Impact
More from GODFRYPHLP